---
title: Comparison of Two Different Diets on Health Outcomes
nct_id: NCT00269646
overall_status: UNKNOWN
phase: NA
sponsor: University of Virginia
study_type: INTERVENTIONAL
primary_condition: Metabolic Syndrome X
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00269646.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00269646"
ct_last_update_post_date: 2009-02-18
last_seen_at: "2026-05-12T06:14:49.285Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Comparison of Two Different Diets on Health Outcomes

**Official Title:** Effect of a Low-Carbohydrate and High-Carbohydrate, High-Fiber Diet on Insulin Sensitivity and Risk Markers for Cardiovascular Disease in Men and Women With the Metabolic Syndrome

**NCT ID:** [NCT00269646](https://clinicaltrials.gov/study/NCT00269646)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 24
- **Lead Sponsor:** University of Virginia
- **Conditions:** Metabolic Syndrome X
- **Start Date:** 2004-11
- **Completion Date:** 2009-08
- **CT.gov Last Update:** 2009-02-18

## Brief Summary

The purpose of this study is to compare the effects of a low-carbohydrate diet and a high-carbohydrate, high-fiber diet, on insulin sensitivity and blood chemicals considered risk markers for heart disease, in persons with the metabolic syndrome.

Our primary hypothesis is that the ad libitum high-carbohydrate, high-fiber diet will significantly improve insulin sensitivity, whereas the ad libitum low-carbohydrate, low-fiber diet will not.

## Detailed Description

Low-carbohydrate eating is becoming perceived as more than just a weight loss diet, but rather a means to improve health. Several studies have been published suggesting that low-carbohydrate diets may be preferable to low-fat diets for weight loss and in terms of some health markers. On the other hand, considerable evidence suggests that low-carbohydrate diets, high in fat, are associated with a number of adverse health outcomes. The health benefits of high-carbohydrate, high-fiber diets have also been demonstrated. This study is designed to assess the differences between the two different dietary strategies in terms of a number of health outcomes. Participants will consume, in random order, a non-calorie-restricted low-carbohydrate and a non-calorie-restricted high-carbohydrate, high-fiber diet for one month, with a 4-6 week washout period in between.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 64 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

1\. Subjects must meet the criteria of the metabolic syndrome, which is defined as having three or more of the following:

* Waist circumference: \>94 cm for males; \>80 cm for females
* Blood Pressure: \>130/85 mmHg
* HDL-Chol (mg/dl): \<50 women; \<40 men)
* Triglycerides (mg/dl): \>150
* Glucose (mg/dl): \>100 2. Subjects must meet age requirement 3. Subjects must be nonsmokers 4. Subjects must be willing to provide written consent 5. Subjects must be willing to pick-up up meals at the GCRC and return uneaten food 6. Have no food allergies 7. Subjects must not be currently following any particular diet, and must not have intentionally lost weight by dieting during the previous 3 months 8. Subjects must not be taking nutritional supplements other than a daily multivitamin 9. Subjects must be willing to maintain current physical activity routine, which cannot exceed the equivalent of \> 30 minutes per day of moderate-intensity activity 10. Blood hematocrit must be at least 40 for men and 36 for women.

Exclusion Criteria:

1\. Does not meet the criteria for the metabolic syndrome 2. Does not meet age requirement 3. Smoker 4. Pregnancy 5. Food allergies 6. Unwillingness to provide written consent 7. Personal history of cardiovascular disease, including prior myocardial infarction, angioplasty, or bypass surgery 8. Known cardiovascular or metabolic diseases (e.g., diabetes) 9. Currently using medications to control blood pressure, lipids, or glucose 10. Currently on a diet or has attempted weight loss by dieting during the past 3 months 11. Currently taking nutritional supplements other than a daily multivitamin 12. Currently exercising more than the equivalent of 30 minutes/day of moderate-intensity physical activity 13. Currently on oral contraceptives 14. Hematocrit below 40 for men or below 36 for women 15. Baseline systolic blood pressure below 100 mmHg

\-
```

## Interventions

- **Low-carbohydrate and high-carbohydrate diets** (BEHAVIORAL) — Each subject will consume two different ad libitum diets, each for four weeks, with a 4-week washout period inbetween each diet.

## Primary Outcomes

- **insulin sensitivity** _(time frame: before and after one month on each diet)_

## Secondary Outcomes

- **Total and LDL-cholesterol** _(time frame: before and after one month on each diet)_
- **C-reactive protein** _(time frame: before and after one month on each diet)_
- **Homocysteine** _(time frame: before and after one month on each diet)_
- **Fibrinogen** _(time frame: before and after one month on each diet)_
- **Cytokines IL-1, IL-2, IL-6 and TNF-alpha** _(time frame: before and after one month on each diet)_
- **Leukocyte adhesion molecules** _(time frame: before and after one month on each diet)_
- **Flow-mediated dilation** _(time frame: before and after one month on each diet)_

## Locations (1)

- University of Virginia General Clinical Research Center, Charlottesville, Virginia, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university of virginia general clinical research center|charlottesville|virginia|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00269646.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00269646*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*